Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Carotid atherosclerosis is a common complication in patients with type 2 diabetes mellitus (T2DM) and is closely associated with an increased risk of cardiovascular events.
Aim: To identify the key demographic, clinical, and biochemical factors associated with carotid plaque formation in T2DM patients and evaluate their predictive value.
Methods: This retrospective study included 266 T2DM patients (control group, = 158; observation group, = 108) recruited between January 2021 and July 2024. Participants underwent carotid ultrasonography to measure intima-media thickness (IMT) and detect carotid plaques. Comprehensive demographic and biochemical data, including age, body mass index (BMI), fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), serum creatinine (Scr), urinary albumin-to-creatinine ratio (UACR), and serum uric acid (SUA), were collected. Statistical analyses, including Pearson correlation, logistic regression, and receiver operating characteristic (ROC) curve analysis, were performed to identify and evaluate factors associated with carotid plaque formation.
Results: Significant differences in age, BMI, HbA1c, FPG, Scr, UACR, and SUA were observed between groups (all < 0.05). Pearson correlation analysis showed IMT was positively associated with age, FPG, HbA1c, Scr, UACR, and SUA, and negatively with HDL-C. Multivariate logistic regression identified age (OR = 1.050, 95%CI: 1.015-1.087), FPG (OR = 1.096, 95%CI: 1.006-1.192), HbA1c (OR = 1.234, 95%CI: 1.057-1.445), SBP (OR = 1.018, 95%CI: 1.002-1.034), Scr (OR = 1.029, 95%CI: 1.011-1.046), UACR (OR = 1.024, 95%CI: 1.010-1.037), SUA (OR = 1.006, 95%CI: 1.003-1.009), and HDL-C (OR = 0.329, 95%CI: 0.119-0.917) as independent predictors of IMT (all < 0.05). ROC analysis showed UACR (AUC = 0.718) and SUA (AUC = 0.651) had predictive value for carotid plaque.
Conclusion: This study highlights the multifactorial nature of carotid atherosclerosis in T2DM, with age, BMI, poor glycemic control, renal dysfunction, and metabolic disturbances identified as key risk factors. The findings underscore the importance of comprehensive risk assessment and targeted interventions to prevent vascular complications in this high-risk population.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362427 | PMC |
| http://dx.doi.org/10.4239/wjd.v16.i8.104180 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Single-Cell Analysis Reveals a Critical Role for Macrophage Epsins in Regulating the Origin of Foam Cells in Atherosclerosis.
Arterioscler Thromb Vasc Biol
September 2025
Vascular Biology Program, Boston Children's Hospital and Harvard Medical School, MA (K. Cui, B.Z., B.W., S.E.-B., A.V., H.C.).
Background: Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipid-laden foam cells and plaques within the arterial wall. Dysfunctional vascular smooth muscle cells (VSMCs), fibroblasts, endothelial cells, and macrophages contribute to disease progression. Here, we report that macrophage-specific expression of epsins, highly conserved endocytic adaptor proteins involved in clathrin-mediated endocytosis, accelerates atherosclerosis in Western diet-fed mice.
View Article and Find Full Text PDFBiological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension.
Arterioscler Thromb Vasc Biol
September 2025
Faculty of Medicine, Department of Physiology, University of Iceland, Reykjavik (G.K.).
Biological sex influences the life course development of blood pressure, systemic arterial hypertension, and hypertension-associated complications through neural, hormonal, renal, and epigenetic mechanisms. Sex hormones influence blood pressure regulation through interaction with several main regulatory systems, including the autonomic nervous system, the renin-angiotensin-aldosterone system, endothelin, and renal mechanisms. The modulation of vascular function by sex hormones varies over the lifespan.
View Article and Find Full Text PDFMajor ABO-Incompatible Platelet Transfusions Are Associated With Brain Ischemia After Intracerebral Hemorrhage.
Stroke
September 2025
Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York. (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.).
Background: Major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet drivers for this relationship remain unclear. Brain magnetic resonance imaging (MRI) ischemic lesions after ICH are neuroimaging biomarkers of secondary brain injury and are associated with poor outcomes. Given that ABO-incompatible platelet transfusions can induce immune complex formation, thrombo-inflammation, and endothelial barrier disruption, factors that could exacerbate cerebral ischemia, we explored whether major ABO-incompatible platelet transfusions are risk factors for ischemic lesions on brain MRI after ICH.
View Article and Find Full Text PDFIn-Flight Deterioration Occurs Early in Aeromedical Trauma Patients.
Emerg Med Australas
October 2025
Australian Centre for Health Services Innovation, School of Public Health & Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Reliably defining the risk of adverse in-flight events in aeromedical trauma patients could enable more informed pre-departure treatment and guide central asset allocation to achieve better system-level outcomes. Unfortunately, the current literature base specifically examining the in-flight period is sparse. Flight duration is often considered a proxy for the risk of in-flight deterioration; however, there is limited data to support this commonly held assumption.
View Article and Find Full Text PDFLarge-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk.
Circ Genom Precis Med
September 2025
Division of Cardiology, Emory University School of Medicine, Atlanta, GA. (A.K.Y., A.C.R., L.S.S., A.A.Q., Y.V.S.).
Background: Cardio-kidney-metabolic (CKM) disease represents a significant public health challenge. While proteomics-based risk scores (ProtRS) enhance cardiovascular risk prediction, their utility in improving risk prediction for a composite CKM outcome beyond traditional risk factors remains unknown.
Methods: We analyzed 23 815 UK Biobank participants without baseline CKM disease, defined by -Tenth Revision codes as cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral arterial disease, atrial fibrillation/flutter), kidney disease (chronic kidney disease or end-stage renal disease), or metabolic disease (type 2 diabetes or obesity).